九州通2023年年报&2024Q1报解读电话会议

Summary of the Conference Call Company and Industry - The conference call pertains to 信达医药 (Innovent Biologics) and 九州通 (JiuZhou Tong) for the year 2023 annual report and 2024 QE report interpretation [1] Core Points and Arguments - The call began with a disclaimer, indicating the importance of the information being discussed and the confidentiality of the content [1] Other Important but Possibly Overlooked Content - All participants were initially muted, suggesting a structured approach to the meeting and a focus on the presentation of information before opening the floor for questions [1]